CRS Clinical Research Services Management GmbH
- Address
- Aprather Weg 18a, Uellendahl-Katernberg, 42113 Wuppertal, Germany
Cardiovascular Diseases
The research program at CRS Clinical Research Services Management GmbH addresses major Cardiovascular Diseases, aiming to improve treatment options and understand drug behavior in the body.
- Acute ischemic stroke
- Heart failure with left ventricular ejection fraction ≥40%
- Pharmacokinetic and bioequivalence studies of anticoagulant and mineralocorticoid receptor antagonist therapies
- Safety and tolerability assessments in healthy volunteers
Ongoing trials evaluate how new compounds influence disease outcomes and drug exposure, supporting the development of more effective cardiovascular therapies.
Hormonal Diseases
At CRS Clinical Research Services Management GmbH investigators explore Hormonal diseases, focusing on sex‑hormone related conditions and their impact on quality of life.
- Vasomotor symptoms in women and men
- Sex hormone‑dependent disorders
- First‑in‑human safety and pharmacokinetic profiling of novel hormone modulators
- Evaluation of drug formulations in healthy participants
These studies aim to establish safe dosing strategies and advance therapeutic options for hormone‑related disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Bayer AG4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CRS Clinical Research Services Management GmbH
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (21751) First-in-human single dose escalation study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of BAY 3018250 in healthy men in a randomized, placebo-controlled, single-blind, group-comparison design | Bayer AG | Phase I | Not Recruiting | Nov 2022 | May 2023 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Elinzanetant | 2 | Unknown | 2022-08-02 | 2023-09-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.